SEC Form D · Amendment · filed August 11, 2023
Duo Oncology Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Robert W. Sperry · Dallas, TXExec · Director · PromoterJingjing Sun · PITTSBURGH, PAPromoterSong Li · PITTSBURGH, PADirector · PromoterRobert Ashley · PITTSBURGH, PADirectorDaniel J. Hopkin · Dallas, TXExec · PromoterJay J. Desai · Dallas, TXDirectorJeffrey Zimmerman · Grand Junction, CODirectorJulie B. Benoist · Dallas, TXDirectorJeffrey A. Hagar · Atlanta, GADirectorSam Rothstein · PITTSBURGH, PAExec · Director · PromoterOren Barzilai · Palo Alto, CAExec · Director · PromoterJoel R. Ward · Atlanta, GAPromoterStanley Marks · PITTSBURGH, PADirectorDan Meader · Southlake, TXExec · PromoterJing-Zhou Hou · PITTSBURGH, PAExec · PromoterKendal H. Strickland · Atlanta, GAExec · PromoterKevin E. Elliott · Dallas, TXPromoterStephen Thorne · PITTSBURGH, PAExec · PromoterOren S. Barzilai · Palo Alto, CADirector · PromoterYanir Ram · Lancaster, CADirector · PromoterJeffrey L. Moredock · Dallas, TXExec · Promoter Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗